Neither the “Devil’s Lettuce” nor a “Miracle Cure:” The Use of Medical Cannabis
Margot Gunning, Ari Rotenberg, James Anderson et al. | Published on 3/25/2022
Lack of guidance and regulation for authorizing medical cannabis for conditions involving the health and neurodevelopment of children is ethically problematic as it promulgates access inequities, risk-benefit inconsistencies, and inadequate consent mechanisms. In two virtual sessions using participatory action research and consensus-building methods, we obtained perspectives of stakeholders on ethics and medical cannabis for children and youth. Read more
here.
All News / Articles